EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Botulinum toxin for Raynaud's phenomenon associated with systemic sclerosis: comment on the article by Senet et al

Hanlin Yin iD, Bei Liu, Qianqian Li, Qingran Yan iD, Liangjing Lu iD

Arthritis & Rheumatology · 2023

DOI: 10.1002/art.42379 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Arthritis & Rheumatology, 2023. Verfasst von Hanlin Yin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Botulinum Toxins, Raynaud Disease, Scleroderma, Systemic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disclosure Form Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum ToxinsRaynaud DiseaseScleroderma, SystemicHumans

Substanzen

Botulinum Toxins

Autor:innen und Institutionen

  • Department of Rheumatology Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Hanlin Yin, Qingran Yan, Liangjing Lu

Zitieren

APA

Yin, H., Liu, B., Li, Q., Yan, Q., & Lu, L. (2023). Botulinum toxin for Raynaud's phenomenon associated with systemic sclerosis: comment on the article by Senet et al. Arthritis & Rheumatology. https://doi.org/10.1002/art.42379

Vancouver

Yin H, Liu B, Li Q, Yan Q, Lu L. Botulinum toxin for Raynaud's phenomenon associated with systemic sclerosis: comment on the article by Senet et al. Arthritis & Rheumatology. 2023. doi:10.1002/art.42379

BibTeX
@article{Yin2023,
  author = {Yin, Hanlin and Liu, Bei and Li, Qianqian and Yan, Qingran and Lu, Liangjing},
  title = {Botulinum toxin for Raynaud's phenomenon associated with systemic sclerosis: comment on the article by Senet et al},
  journal = {Arthritis & Rheumatology},
  year = {2023},
  doi = {10.1002/art.42379}
}
Kostenlos starten →